Med. Pro Praxi 2005; 1: 28-31

MIGRÉNA - Nová mezinárodní klasifikace a moderní léčebné postupy

MUDr. Jiří Mastík
Neurologická klinika LF MU a FN u sv. Anny, Brno

Migréna představuje odedávna závažný medicínský, ale i socioekonomický problém. Názory na etiopatogenezu migrény se postupně vyvíjejí a doplňují. V současné době se uznává komplexní neurogenní teorie s aktivací trigeminovaskulárního komplexu. V září 2003 byla zveřejněna nová Mezinárodní klasifikace bolestí hlavy. V práci jsou podrobně diskutována diag­nostická kritéria jednotlivých typů migrény. Strategie moderní léčby migrény využívá kombinace vhodné profylaktické kúry, která má zajistit 50% redukci migrenózních záchvatů, a účinné akutní léčby včetně skupiny specifických antimigrenik, triptanů, kterou přeléčíme zbývající ataky.

Keywords: Klíčová slova: migréna, etiopatogeneza migrény, trigeminovaskulární komplex, klasifikace bolestí hlavy, profylaktická kúra, triptany.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mastík J. MIGRÉNA - Nová mezinárodní klasifikace a moderní léčebné postupy. Med. praxi. 2005;2(1):28-31.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Diamond S, Medina TL. Headaches. Clinical Symposia 1989; 41: 2-32. Go to PubMed...
    2. Diener HC, May A. New aspects of migraine pathophysiology: lessons learned from positron emission tomography. Current Opinion in Neurology 1996; 9: 199-201. Go to original source... Go to PubMed...
    3. Dočekal P. Socioekonomické aspekty migrény. Neurologie pro praxi 2003; 2: 67-68.
    4. Hanington E. Migraine: A blood disorder? Lancet II 1978; 8088: 501-503. Go to original source... Go to PubMed...
    5. Hanington E, Jones RT, Ames TLA, Wachowicz B. Migraine. A platelet disorder. Lancet II 1981; 8249: 720-723. Go to original source... Go to PubMed...
    6. Headache Classification Subcommittee of the International Headache Society: The international classification of headache disorders. Cephalalgia 2004; (Suppl.1): 1-160.
    7. Kotas R, Ambler Z, Souček R. Současná farmakoterapie migrény. Remedia 1992; 2: 230-247.
    8. Lauritzen M. Spreading depression and migraine. Pathol Biol Paris 1992; 40: 332-337. Go to PubMed...
    9. Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by Xenon 133 inhalation and emission tomography. Brain 1984; 107: 447-461. Go to original source... Go to PubMed...
    10. Leao AAP. Spreading depression of activity in cerebral cortex. J neurophysiol 1944; 7: 359-390. Go to original source...
    11. Mastík J, Novotná I, Štoplová J, Klajblová I, Rektor I. Valproát sodný v profylaktické léčbě migrény. Bolest 2001; 2: 78-82.
    12. Mathew NT. Transformed migraine. Cephalalgia 1993; 13 (Suppl 12): 78-83. Go to original source... Go to PubMed...
    13. Mathew NT, Reuveni V, Perey F. Transformed or evolutive migraine. Headache 1987; 27: 102-106. Go to original source... Go to PubMed...
    14. McGregor A. Migraine in women. London: Martin Duniz 1999. Go to original source...
    15. Moskowitz MA, MacFarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovascr and Brain Metab Rev 1993; 5: 159-177.
    16. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activations of rCBF in classic migraine. Ann Neurol 1981; 9: 344-352. Go to original source... Go to PubMed...
    17. Ophoff RA, Terwindt GM, Vergouve MN, van Eijk RV, Oefner PJ, Hoffman SMG, et al. Familial hemiplegic migraine and episodic ataxia type-2 caused by mutations in the Ca2+ channel gene CACNL1 A4. Cell 1996; 87: 543-552. Go to original source... Go to PubMed...
    18. Pearce JMS. Migraine. A cerebral disorder. Lancet II 1982; 8394: 86-89. Go to original source...
    19. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986; 36: 995-997. Go to original source... Go to PubMed...
    20. Siccuteri F, Testi A, Anselmi B. Biochemical investigations in headache: Increase in hydroxyindolaecetic acid excretion during migraine attacks. Int Arch Allergy Appl Immun 1961; 19: 55-58. Go to original source...
    21. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race and other sociodemographic factors. JAMA 1992; 267: 64-69. Go to original source... Go to PubMed...
    22. Thomsen LL. Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache. Cephalalgia 1997; 17: 873-895. Go to original source... Go to PubMed...
    23. Waberžinek G. Migréna - diagnostika a léčba. Praha: Triton 2003: 158s.
    24. Weiller C, May A, Limmroth V, Juptner M, Kaube H, van Schayck R, Coenen HH, Diener HC. Brainstem activation in human migraine attacks. Nature Med 1995; 1: 658-660. Go to original source... Go to PubMed...
    25. Wolff HG. Headache and other head pain. New York: Oxford University Press 1963: 632.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.